臺大學術典藏 |
2021-01-28T02:02:58Z |
Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study
|
Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; Chang H.-C.; Lin W.-C.; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-28T02:02:49Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-28T02:02:46Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-28T02:02:46Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Chow P.-M.;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Kuo-How Huang; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-28T02:02:45Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-28T02:02:44Z |
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-28T02:02:43Z |
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
|
Shi C.-S.;Kuo K.-L.;Chen M.-S.;Chow P.-M.;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Chang H.-C.;Kuo-How Huang; Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; KUO-HOW HUANG |
臺大學術典藏 |
2021-01-26T02:27:45Z |
2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells
|
Kuo K.-L.; Lin W.-C.; Ho I.-L.; HONG-CHIANG CHANG; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:42Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.;Ho I.-L.;Shi C.-S.;Wu J.-T.;Lin W.-C.;Tsai Y.-C.;Hong-Chiang Chang;Chou C.-T.;Hsu C.-H.;Hsieh J.-T.;Chang S.-C.;Pu Y.-S.;Huang K.-H.; Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; Tsai Y.-C.; HONG-CHIANG CHANG; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:42Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Hong-Chiang Chang;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Liu S.-H.;Jeng Y.-M.;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; HONG-CHIANG CHANG; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; Jeng Y.-M.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:39Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; HONG-CHIANG CHANG; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:37Z |
Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study
|
Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; HONG-CHIANG CHANG; Lin W.-C.; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:34Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Chow P.-M.;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Hong-Chiang Chang;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; HONG-CHIANG CHANG; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:34Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Hong-Chiang Chang;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; HONG-CHIANG CHANG; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:33Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Hong-Chiang Chang;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; HONG-CHIANG CHANG; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:33Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Hong-Chiang Chang;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; HONG-CHIANG CHANG; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:31Z |
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
|
Shi C.-S.;Kuo K.-L.;Chen M.-S.;Chow P.-M.;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Hong-Chiang Chang;Huang K.-H.; Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; HONG-CHIANG CHANG; Huang K.-H. |
臺大學術典藏 |
2021-01-26T02:27:31Z |
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Hong-Chiang Chang;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; HONG-CHIANG CHANG; Huang K.-H. |
臺大學術典藏 |
2020-03-06T08:25:03Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; YUNG-MING JENG; Huang K.-H.; Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Liu S.-H.;Yung-Ming Jeng;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C. |
臺大學術典藏 |
2020-01-23T01:37:24Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
臺大學術典藏 |
2020-01-23T01:37:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Huang K.-H.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y. |
臺大學術典藏 |
2020-01-23T01:37:23Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Po-Ming Chow;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
臺大學術典藏 |
2019-11-12T07:36:33Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Shing-Hwa Liu;Jeng Y.-M.;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; SHING-HWA LIU; Jeng Y.-M.; Huang K.-H. |
臺大學術典藏 |
2019-11-12T07:36:21Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H.; Lin W.-C.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Shing-Hwa Liu;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H. |
臺大學術典藏 |
2019-11-12T07:36:17Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Shing-Hwa Liu;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |